我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

不同血糖控制水平对2型糖尿病患者左室结构和功能的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第6期
页码:
699-702
栏目:
临床研究
出版日期:
2015-07-15

文章信息/Info

Title:
Effect of glycemic control on progression of left ventricular hypertrophy and diastolic dysfunction in patients with type 2 diabetes mellitus
作者:
吴龙飞1; 徐世成2; 刘春燕3; 康国平4; 朱 宇3; 刘芙蓉1; 李 林1
(巴中市中心医院、川北医学院附属巴中医院：1.心内科，2.重症医学科，3.呼吸内科，4.急诊科，四川 巴中 636000)
Author(s):
WU Long-fei1;  XU Shi-cheng2;  LIU Chun-yan3;  KANG Guo-ping4;  ZHU Yu3;  LIU Fu-rong1;  LI Lin1
(1.Department of Cardiology, 2.Intensive Care Unit, 3.Department of Respiratory Medicine, 4.Emergency Department, Bazhong Central Hospital, Bazhong 636000, Sichuan, China)
关键词:
血糖控制; 2型糖尿病; 左室结构; 左室舒张功能
Keywords:
glycemic control;  type 2 diabetes mellitus;  left ventricular structure;  left ventricular diastolic function
分类号:
R587.1
DOI:
-
文献标识码:
A
摘要:
目的 探讨不同血糖控制水平对2型糖尿病患者左室结构和功能的影响。方法 选择2009年9月~2011年1月于巴中市中心医院就诊的2型糖尿病患者40例作为糖尿病组，另选择性别年龄匹配的健康志愿者40例为正常对照组。对糖尿病组患者进行规范化治疗，观察期24个月，比较治疗前后患者左室结构和功能的超声学参数。随访末，根据血糖控制水平将糖尿病组分为良好组(HbA1c<7.6%，n=17)、中等组(7.6%≤HbA1c≤9%，n=14)和不良组(HbA1c>9%，n=9) 3个亚组，比较随访前后3组的超声学参数的变化。结果 在基线水平糖尿病等容舒张期时间（IVRT）糖尿病组明显高于对照组(P<0.05)，E/A低于对照组(P<0.05)，两组在室间隔厚度（IVS）、左室后壁厚度（LVPW）、左室舒张末内径（LVEDD）及左室收缩功能等方面差异无统计学意义；随访前后，血糖控制良好组左室结构和功能超声参数差异无统计学意义；中等组和不良组不同程度地出现IVS、LVPW及左室质量指数(LVMI)增加， IVRT延长和E/A降低，差异均有统计学意义(P<0.05)。结论 2型糖尿病患者容易发生左室舒张功能减退，积极控制血糖可以延缓左室肥厚的发生，但不能改善左室舒张功能，血糖控制不良会加速左室重构和加重左室舒张功能不全。
Abstract:
AIM To investigate the effect of glycemic control on the progress of left ventricular hypertrophy and diastolic dysfunction in patients with type 2 diabetes mellitus (T2DM). METHODS A total of 40 T2DM patients (observation group) and 40 age-matched healthy controls (control group) were recruited. Patients in the observation group received standard treatment for glycemic control (including diabetes education, self-blood glucose monitoring and daily exercise). All patients were followed-up after 24 months and were evaluated by echocardiography to compare the left ventricular structural and functional parameters. At the end of our study, patients in the observation group were stratified into three subgroups according to glycemic level: well-controlled group (HbA1c<7.6%, n=17), mildy controlled group (7.6%≤HbA1c≤ 9%, n=14), and poorly controlled group (HbA1c>9%, n=9) respectively. Echocardiographic parameters were compared among the three groups before and after follow-up. RESULTS IVSd, LVPW, LVEDd and cardiac systolic function were similar between groups. IVRT was elevated but E/A decreased in the observation group compared with those in the control group at baseline (P<0.05). No significant differences were found in the echocardiographic parameters of left ventricular structure and function in well-controlled patients. The mildly controlled group and poorly controlled group demonstrated increased IVSd, LVPWd and LVMI, and exacerbated left ventricular diastolic function with prolonged IVRT and decreased E/A. In addition, patients receiving metformin therapy demonstrated a significant reduction in IVRT and E/A compared with patients receiving insulin therapy. CONCLUSION ST2DM patients tend to develop left ventricular diastolic dysfunction. Improved glycemic control can delay the progress of LVH, but cannot ameliorate the decreased diastolic dysfunction. Poor glycemic control can accelerate left ventricular remodeling and exacerbate diastolic dysfunction in patients with T2DM.

参考文献/References

[1]Eurich DT,Mcalister FA,Blackburn DF,et al.Benefits and harms of antidiabetic agents in patients with diabetes and heart failure:systematic review[J].BMJ,2007,335(7618):497-507.
[2]Pappachan JM,Varughese GI,Sriraman R,et al.Diabetic cardiomyopathy: Pathophysiology,diagnostic evaluation and management[J].World J Diabetes,2013,4(5):177-189.
[3]Ward ML,Crossman DJ.Mechanisms underlying the impaired contractility of diabetic cardiomyopathy[J].World J Cardiol,2014,6(7):577-584.
[4]Letonja M,Petrovic D.Is diabetic cardiomyopathy a specific entity?[J].World J Cardiol,2014,6(1):8-13.
[5]Cosson S,Kevorkian JP.Left ventricular diastolic dysfunction:an early sign of diabetic cardiomyopathy?[J].Diabetes Metab,2003,29(5):455-466.
[6]El Dayem SM,Battah AA.Effect of glycemic control on the progress of left ventricular hypertrophy and diastolic dysfunction in children with type I diabetes mellitus[J].Anadolu Kardiyol Derg,2012,12(6):498-507.
[7]Cheitlin MD,Armstrong WF,Aurigemma GP,et al.ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines（ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography）[J].J Am Soc Echocardiogr,2003,108(9):1146-1162.
[8]Devereux RB,Alonso DR,Lutas EM,et al.Echocardiographic assessment of left ventricular hypertrophy:comparison to necropsy findings[J].Am J Cardiol,1986, 57(6):450-458.
[9]From AM, Scott CG,Chen HH.Changes in diastolic dysfunction in diabetes mellitus over time[J].Am J Cardiol,2009,103(10):1463-1466.
[10]向忠民.糖调节受损患者左室舒张功能观察[J].心脏杂志,2013,25(6):753.
[11]Vintila VD,Roberts A,Vinereanu D,et al.Progression of subclinical myocardial dysfunction in type 2 diabetes after 5 years despite improved glycemic control[J].Echocardiography,2012,29(9):1045-1053.
[12]Huynh K,Bernardo BC,Mcmullen JR,et al.Diabetic cardiomyopathy:mechanisms and new treatment strategies targeting antioxidant signaling pathways[J].Pharmacol Ther,2014,142(3):375-415.
[13]黄 海,宋成运,李运田.糖尿病性心肌病发病的统一机制——氧化应激[J].心脏杂志,2013,25(2):246-249.
[14]Pitale SU,Abraira C,Emanuele NV,et al.Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus(VA CSDM)[J].Diabetes Care,2000,23(9):1316-1320.
[15]Ofstad AP,Johansen OE,Gullestad L,et al.Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes:The randomized controlled Asker and B?rum Cardiovascular Diabetes (ABCD) study[J].Am Heart J, 2014, 168(3):280-288.

备注/Memo

备注/Memo:
收稿日期：2014-08-13.
基金项目：四川省卫生厅科研课题资助（120517）；四川省医学会“施慧达”科研课题资助(SHD14-13)
作者简介：吴龙飞，主治医师，硕士 Email:taoguox@hotmail.com
更新日期/Last Update: 2015-07-23